Transuite.org notifies late 2025 10-K filing
Transuite.org Inc. submitted a Form 12b-25 notifying the SEC that its Form 10-K for the year ended December 31, 2025 could not be filed on time due to difficulties finalizing audit materials that could not be eliminated without unreasonable effort or expense.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Transuite.org Inc. submitted a Form 12b-25 notifying the SEC that its Form 10-K for the year ended December 31, 2025 could not be filed on time due to difficulties finalizing audit materials that could not be eliminated without unreasonable effort or expense.
The filing discloses a $32,000,000 net loss for 2025 versus $375,000 in 2024, largely driven by approximately $32,000,000 of stock-based compensation issued to consultants. The company recognized total revenue of approximately $118,000 in 2025, reported total assets of roughly $15,000,000 as of December 31, 2025 (including about $14,700,000 of goodwill), and total liabilities of approximately $82,000.
Insights
Late 10-K stems from audit completion issues tied to complex acquisitions and sizable noncash charges.
The company states the Form 10-K was delayed because audit materials could not be finalized without unreasonable effort or expense. The filing explicitly links large, noncash stock-based compensation (~$32,000,000) and acquisition-related items to the 2025 results.
Key dependencies include completion of audit work around purchase accounting and valuation of goodwill and deferred share issuance cost; subsequent periodic filings should confirm auditors' adjustments and any revised metrics.
Multiple 2025 acquisitions created material balance-sheet items requiring audit scrutiny.
The filing notes eight acquired entities producing about $14,700,000 of goodwill and an increase in deferred share issuance cost (~$690,000), which explain most of the asset growth to $15,000,000 as of December 31, 2025.
Future filings should disclose purchase price allocation details and any impairment testing results; until the 10-K is filed, the precise accounting treatment and potential adjustments remain to be reported.
Key Figures
Key Terms
Rule 12b-25 regulatory
stock-based compensation financial
goodwill financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did TRSO file a Form 12b-25 instead of the 2025 10-K?
How large was Transuite.org's net loss for 2025 as disclosed in the notification?
What balance-sheet changes did TRSO report for year-end 2025?
Did Transuite.org report significant liability changes in 2025?
Will TRSO file the delayed Form 10-K and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.